| abstract |
The present disclosure relates to the design and synthesis of novel mitochondrial-tropic antioxidant compounds based on hydroxybenzoic acids and analogs. Furthermore, the present disclosure relates to methods and uses of hydroxybenzoic acid-based derivatives and analogues, for example, in the field of human and animal diseases, for example, for the treatment of mitochondrial dysfunction or mitochondrial defects, and in the field of cosmetics, for example, for the prevention of Or delay skin aging. |